Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendavia for reperfusion injury after primary PCI in anterior STEMI
2011-002824-42Phase 2Completed
- Sponsor
- Stealth BioTherapeutics
- Start
- Feb 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) and acute ST-segment elevation myocardial infarction (STEMI) comparing Bendavia with Placebo (2 arms). Primary endpoint: Area under the CK-MB curve over 72 hours after PCI. Started Feb 2012; status: completed.
02
Drugs
elamipretide
03
Conditions
myocardial infarction (MI)acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2011-002824-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002824-42.